Kol Bio-Medical Instrs Inc is categorized under in Chantilly, VA and active since 1971.
Kol Bio-Medical Instrs Inc was established in 1971, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 4234502 by the NAICS.
If you are seeking more information, feel free to contact Timothy Mcinerney, Chief Executive Officer at the company’s single location by writing to 13901 Willard Road, Chantilly, Virginia VA 20151 or by phoning (703) 378-8600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kol Bio-Medical Instrs Inc |
| Contact Person: | Timothy Mcinerney, Chief Executive Officer |
| Address: | 13901 Willard Road, Chantilly, Virginia 20151 |
| Phone Number: | (703) 378-8600 |
| Website Address: | kolbio.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 1971 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 5047 |
| NAICS Code: | 4234502 |
| Share This Business: |
Kol Bio-Medical Instrs Inc was started in 1971 to provide professional under the SIC code 5047 and NAICS code 4234502. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Timothy Mcinerney, Chief Executive Officer for inquiries that concern Kol Bio-Medical Instrs Inc by calling the company number (703) 378-8600, as your correspondence is most welcome. Additionally, the physical location of the single location of Kol Bio-Medical Instrs Inc can be found at the coordinates 38.8863,-77.43118 as well as the street address 13901 Willard Road in Chantilly, Virginia 20151.
For its online presence, you may visit Kol Bio-Medical Instrs Inc’s website at kolbio.com and engage with its social media outlets through on Twitter and on Facebook.